IO Biotech, Inc. - Common stock, par value $0.001 per share (IOBT)

Historical Holders from Q4 2021 to Q3 2025

Symbol
IOBT on Nasdaq
Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
65,606,830
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
9,895,875
Holdings value
$3,589,663
% of all portfolios
0%
Number of holders
21
Number of buys
14
Number of sells
-19
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IO Biotech, Inc. - Common stock, par value $0.001 per share (IOBT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HBM Healthcare Investments (Cayman) Ltd. 8.2% $5,412,970 5,523,439 HBM Healthcare Investments (Cayman) Ltd. 31 Dec 2023
Novo Holdings A/S 7.3% $10,560,967 4,981,588 Novo Holdings A/S 11 Aug 2025
Chernett Jorey 5.3% $1,286,550 3,477,162 Chernett Jorey 30 Oct 2025
Samsara BioCapital, L.P. 3.8% $2,578,946 2,631,578 Samsara BioCapital, L.P. 31 Dec 2024

Institutional Holders of IO Biotech, Inc. - Common stock, par value $0.001 per share (IOBT)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 9,895,875 $3,589,663 -$13,417,589 $0.3631 21
2025 Q2 18,182,707 $25,273,480 -$1,285,024 $1.39 26
2025 Q1 19,066,617 $20,781,978 -$660,538 $1.09 21
2024 Q4 19,692,862 $18,114,763 -$4,833,042 $0.9200 26
2024 Q3 23,591,882 $24,769,965 -$2,959,503 $1.05 19
2024 Q2 26,183,049 $30,634,167 -$1,443,320 $1.17 19
2024 Q1 27,341,910 $47,354,293 -$3,558,302 $1.73 17
2023 Q4 29,400,721 $55,273,224 +$999,356 $1.88 18
2023 Q3 29,668,665 $41,702,613 +$24,426,263 $1.41 19
2023 Q2 12,246,779 $23,953,554 -$3,111,706 $1.96 15
2023 Q1 13,917,553 $26,081,803 -$1,175,062 $1.88 17
2022 Q4 14,281,285 $32,846,954 -$2,578,155 $2.30 17
2022 Q3 15,335,530 $41,559,000 -$326,875 $2.71 20
2022 Q2 15,453,557 $72,167,000 +$2,681,635 $4.67 18
2022 Q1 14,858,852 $76,863,500 -$1,060,884 $5.30 19
2021 Q4 12,982,583 $82,349,000 +$82,349,000 $6.40 19